Check out the companies making headlines in the midday deal: Auto Stock – Major car manufacturers skated on April 2 following President Donald Trump’s plan to impose a 25% tariff on “all cars not made in the US.” GameStop – Memestock fell 22% on Thursday, following nearly 12% meetings from the previous session. The reversal comes after the video game chain announced plans to raise $1.3 billion through the sale of memos from the conversion factory scheduled to buy Bitcoin in 2030. Jefferies Financial Group – Shares plummeted 10% after Jefferies reported first-quarter earnings of $1.59 billion per share. This marked a decline from 69 cents in revenue and revenue for the same period last year and revenue of $1.74 billion. Alibaba – After Alibaba launched its latest open source artificial intelligence model, US registered stocks of Chinese e-commerce stocks jumped nearly 3%. The new model, “QWEN2.5-OMNI-7B”, is multimodal and can be used with edge devices such as mobile phones. Verint Systems – Customer engagement platform provider fell 13% after posting weak results for the fourth quarter and full-year guidance. Verint said it won 99 cents per share, earning revenues of $254 million, with analysts voted by LSEG at $1.27 per share and revenues of $277 million. Advanced Micro Devices – Technology Stocks slipped 3% after Jefferies downgraded its purchases. Liberty Energy – After an upgrade from equal weight to overweight at Morgan Stanley, my energy stock is now 5%. Analyst Daniel Katz said investors can use Liberty Energy to acquire themes of data center exposure and electricity demand growth. Petco Health and Wellness – Stocks skyrocketed 32% after PET Supplies retailers said they expected annual adjusted revenues before interest, taxes, depreciation and amortization to be between $375 million and $390 million. Cava – Mediterranean high-speed casual chain added 2%. Cava is scheduled to replace Altair Engineering on the S&P Midcap 400, the Examention Exaction, on March 31st. WinnebagoIndustries – Motorhome Maker scored 8% after reporting adjusted 19 cents for the second quarter of Fiscal. Meanwhile, the company lowered its full-year outlook. Soleno Therapeutics – The biotechnology company rose 38% after it announced US Food and Drug Administration approval for Vykat XR, which treats overdrinking in patients over 4 years of age with Prader-Willi syndrome. Bulmicidal ejaculation is an extreme and overwhelming hunger commonly associated with patients suffering from hereditary disorders. Constex – Business Tech stocks skyrocketed 42%. Consterix posted top-line and bottom-line beats in the first quarter. Concentix recorded adjusted earnings of $2.37 billion in revenue of $2.79 per share, while analysts expected a profit of $2.58 against revenue of $2.36 billion per fact set. TD Synnex – Shares plummeted 14% after the IT company reported first quarter revenue and revenue errors. According to Factset, TD Synnex also led to second quarter revenue and revenue that was below analyst expectations. Kyndryl – Stocks fell more than 5% after short-seller Gotham City Research argued about IBM costs issues. Stocks fell 4% after Bausch + Lomb – Eye Health Company announced a voluntary recall of intraocular lenses. – CNBC’s Brian Evans, Alex Hurling, Hakyung Kim, Yoon Lee and Sarah Min contributed the report. Get tickets for Pro Live Join us on the New York Stock Exchange! An uncertain market? Earn Edge with CNBC Pro Live, the first exclusive event on the historic New York Stock Exchange. Access to expert insights is paramount in today’s dynamic financial situation. As a CNBC Pro subscriber, we encourage you to take part in the first exclusive, in-person CNBC Pro live event held at the iconic NYSE on Thursday, June 12th. Join ProSCarter Worte, an interactive pro clinic led by Dan Niles and Dan Ives, along with a special edition of Pro Talks with Tom Lee. You will also get the opportunity to network with CNBC experts, talent and other pro subscribers during exciting cocktail hours on the legendary trading floor. Tickets are limited!